US ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis

US ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis


$ 3999

The US ADHD (Attention Deficit Hyperactivity Disorder) therapeutic market is projected to grow from $12.4 Bn in 2022 to $19.1 Bn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. ADHD is one of the most common neurodevelopmental disorders in children, with an estimated prevalence of 6-9% in the US. The rising prevalence of ADHD is driving the demand for effective treatments and contributing to the growth of the market. Some key players in the US ADHD therapeutic market include Shire (now part of Takeda Pharmaceutical Company), Pfizer Inc., Novartis International AG, Johnson & Johnson, Eli Lilly and Company, and GlaxoSmithKline plc.

ID: IN10USPH028 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Shivam Zalke

Buy Now

US ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Executive Summary

A CAGR of 5.5% is anticipated for the US ADHD (Attention Deficit Hyperactivity Disorder) treatment market from 2022 to 2030, growing from $12.4 Bn in 2022 to $19.1 Bn in 2030.

Due to the rising incidence of ADHD and the availability of efficient treatment alternatives, the US therapeutic market for ADHD (Attention Deficit Hyperactivity Disorder) is expanding quickly.

Treatment options for people with ADHD are referred to as ADHD (Attention Deficit Hyperactivity Disorder) Therapy. Inattention, hyperactivity, and impulsivity are some of the symptoms of ADHD, a neurodevelopmental condition. While it is frequently identified in children, ADHD can last until adulthood. Although the precise aetiology of ADHD is unknown, a confluence of genetic, environmental, and neurological factors is thought to be responsible.

Medication, behavioural therapy, and lifestyle changes are just a few of the therapies for ADHD that are available. Stimulants like methylphenidate and amphetamine are the most often recommended treatments for ADHD because they raise dopamine and norepinephrine levels in the brain. For people who do not respond well to stimulants or who have negative effects from them, non-stimulant medicines such as atomoxetine and guanfacine may be utilised.

For those with ADHD, particularly youngsters, behavioural treatment might be helpful. Working with a therapist or counsellor to develop behavioural methods and coping mechanisms that can help control ADHD symptoms is known as behavioural therapy. For those with ADHD, making lifestyle changes like exercising and adopting a nutritious diet may be helpful.

us adhd therapeutics market analysis

Market Dynamics

Market Growth Drivers

Due to the lack of a cure for this disorder, the prevalence of ADHD is increasing at a faster rate, which drives the US market for therapeutics for the condition. Additionally, the market for ADHD therapeutics is primarily driven by the negative effects of unstable lifestyles and food additives on children, which is increasing the prevalence of ADHD in people between the ages of 4 to 17. Additionally, it is predicted that in the near future, the US market for ADHD will experience revenue growth due to rising awareness of the syndrome among doctors and patients as well as opinion-based treatment options caused by the absence of routine diagnostic tests.

Market Restraints

The development of the US market for ADHD therapeutics is being constrained by the high cost of ADHD medications, poor reimbursement policies, and side effects associated with ADHD medications (such as insomnia, anorexia, dizziness, headaches, and mood changes). The adverse effects of ADHD medications also negatively impact patients' quality of life and restrain the market's revenue growth over the given forecast period. Aside from these issues, medications for attention deficit hyperactivity disorder are linked to medical conditions like kidney disease, coronary artery disease, and seizures.

Competitive Landscape

Key Players

  • Shire (currently part of Takeda Pharmaceutical Company) (now part of Takeda Pharmaceutical Company)
  • Pfizer, Inc.
  • Incorporated by Novartis
  • Smith & Johnson
  • Firm named Eli Lilly
  • PLC GlaxoSmithKline
  • Pharmaceutical company Teva Industries Ltd.
  • Impax Laboratories, LLC, Mylan N.V.
  • Pharmaceutical company Mallinckrodt

These businesses also produce additional therapeutic goods including behavioural treatment programmes in addition to a variety of ADHD medicines, including stimulant and non-stimulant drugs. These businesses dominate the market and are responsible for generating both innovation and competition. The development of novel ADHD therapies and technology by several smaller businesses and startups may potentially have an impact on the market in the future.

Healthcare Policies and Regulatory Landscape

The US Food and Drug Administration (FDA) regulates the US ADHD treatment market, which is also subject to a variety of healthcare laws and regulations. Following are some significant laws and rules that affect the market:

  1. FDA Approval: Before being marketed and sold in the US, all ADHD drugs must have FDA approval. The FDA evaluates evidence from clinical trials and other sources to assess the effectiveness and safety of each drug.
  2. The Drug Enforcement Agency (DEA) has classed certain ADHD drugs as Schedule II prohibited narcotics due to their propensity for misuse and dependency. The prescribing and distribution of certain pharmaceuticals are subject to extra rules as a result of this categorization.
  3. Medicaid Coverage: ADHD medicines and other therapeutic interventions are covered by Medicaid for those who qualify, which has a big influence on the market demand for these items
  4. Healthcare insurers are required to cover mental health problems, including ADHD, under the requirements of the Affordable Care Act (ACA). For people with ADHD, this has boosted access to treatment alternatives.
  5. Guidelines for Diagnosis and Treatment: For the diagnosis and management of ADHD, the American Academy of Pediatrics and other medical associations have issued recommendations. These recommendations for best practices might have an effect on how ADHD drugs are prescribed and used.
  6. Adverse Event Reporting: The FDA requires ADHD drug manufacturers to notify it of any adverse events or side effects related to their medicines. This enables continuous monitoring and evaluation of the risks and advantages of certain treatments, helping to assure their safety.

Overall, these laws and rules are crucial in establishing the US ADHD therapeutic market, guaranteeing the effectiveness and safety of ADHD drugs and other therapies, and facilitating access to healthcare for people with ADHD.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

US ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Segmentation

By Drug Type (Revenue, USD Billion):

  • Stimulants
    • Amphetamine
    • Methylphenidate
    • Dextroamphetamine
    • Dexmethylphenidate
    • Lisdexamfetamine
    • Others
       
  • Non-Stimulants
    • Atomoxetine
    • Bupropion
    • Guanfacine
    • Clonidine

By Age Group (Revenue, USD Billion):

  • Pediatric And Adolescent
  • Adult

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Speciality Clinics
  • Retail Pharmacies
  • e-Commerce

By Psychotherapy (Revenue, USD Billion):

  • Behaviour Therapy
  • Cognitive Behavioral Therapy
  • Interpersonal Psychotherapy
  • Family Therapy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 31 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up